Why, if After 7 to 21 Years of Follow-Up Data, Disc Arthroplasty Has a Mere 0.67% Index Level Revision Rate, Is It Not a Standard of Care?

Key Takeaways

• 0.67% index-level revision rate over up to 21 years.
• ODI and VAS scores improved within 3 months and stayed low.
• One- and two-level disc replacements showed equivalent long-term outcomes.
• Prior surgery did not diminish final pain or disability improvement.
• Adjacent-level surgery occurred in only 1.85% of cases.

Pulse Analysis

Lumbar total disc arthroplasty (TDA) has long been positioned as a motion‑preserving alternative to spinal fusion, but skeptics have demanded robust, long‑term data to justify its broader adoption. Early‑generation studies showed promising short‑term pain relief, yet concerns about implant wear, biomechanical failure, and the potential for late‑onset adjacent‑segment disease kept many surgeons anchored to fusion. The recent 2025 JBJS study, encompassing 1,187 patients with follow‑up ranging from seven to twenty‑one years, finally delivers the longitudinal evidence needed to assess TDA’s durability against those historic doubts.

The cohort’s outcomes are striking: index‑level revision occurred in only 0.67% of cases, while adjacent‑level surgery was required in 1.85% of patients—figures that compare favorably to the 10‑15% adjacent‑segment degeneration rates reported in long‑term fusion series. Moreover, functional metrics such as the Oswestry Disability Index and VAS pain scores dropped sharply within three months and remained near‑baseline for the study’s duration. Importantly, the data show parity between single‑ and two‑level disc replacements and demonstrate that prior index‑level surgery does not blunt the ultimate clinical benefit, expanding the candidate pool for motion‑preserving interventions.

For the spine market, these findings could accelerate a shift toward TDA as a mainstream option. Payers may view the low re‑operation rates as a cost‑saving advantage, while surgeons gain confidence in offering multi‑level replacements without compromising durability. The study also underscores the need for continued device‑specific registries to monitor real‑world performance, but its message is clear: well‑designed lumbar disc prostheses can deliver lasting pain relief and functional improvement, positioning them as a viable long‑term standard of care for degenerative disc disease.